XML 43 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Derivative and Other Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2013
General Discussion of Derivative Instruments and Hedging Activities [Abstract]  
Accumulated Other Comprehensive Income (AOCI) and Earnings From Changes In Fair Value Related To Derivative Instruments
The following table sets forth financial information about the impact on Accumulated Other Comprehensive Income (“AOCI”) and earnings from changes in the fair value of derivative instruments.
 
 
 Amount of gain/(loss)
 
 Amount of gain/(loss)
 
 
 
recognized in AOCI
 
reclassified from AOCI
 
 
 
(effective portion)
 
into earnings
 
 
 
Three Months Ended
 
Nine Months Ended
 
Three Months Ended
 
Nine Months Ended
 
Derivatives in cash flow hedges
 
September 30, 2013
 
September 30, 2013
 
September 30, 2013
 
September 30, 2013
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange
 
$
(2
)
 
$
(1
)
 
$
(1
)
 
$

(1) 
Commodities
 
(24
)
 
(38
)
 
(12
)
 
(25
)
(2) 
Total
 
$
(26
)
 
$
(39
)
 
$
(13
)
 
$
(25
)
 

 
 
Amount of gain/(loss)
recognized in AOCI
(effective portion)
 
Amount of gain/(loss)
reclassified from AOCI
into earnings
 
 
 
Three Months Ended
 
Nine Months Ended
 
Three Months Ended
 
Nine Months Ended
 
Derivatives in cash flow hedges
 
September 30, 2012
 
September 30, 2012
 
September 30, 2012
 
September 30, 2012
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange
 
$

 
$
(3
)
 
$

 
$

(3) 
Commodities
 
(58
)
 
(73
)
 
(21
)
 
(39
)
(4) 
Total
 
$
(58
)
 
$
(76
)
 
$
(21
)
 
$
(39
)
 

(1)
Within the Statement of Operations for the three months ended September 30, 2013, a gain of $4 was recognized in cost of products sold and a loss of $5 was recognized in net sales. During the nine months ended September 30, 2013 a gain of $6 was recognized in cost of products sold and a loss of $6 was recognized in net sales.

(2)
Within the Statement of Operations for the three months ended September 30, 2013, a net loss of $16, including a reduction of $2 for ineffectiveness, was recognized in cost of products sold and a tax benefit of $4 was recognized in income tax expense. During the nine months ended September 30, 2013 a loss of $34, including a reduction of $3 for ineffectiveness, was recognized in cost of products sold and a tax benefit of $9 was recognized in income tax expense.

(3)
Within the Statement of Operations for the three months ended September 30, 2012 , a gain of $3 was recognized in cost of products sold and a loss of $3 was recognized in net sales. During the nine months ended September 30, 2012 , a gain of $6 was recognized in cost of products sold and a loss of $7 was recognized in net sales.

(4)
Within the Statement of Operations for the three months ended September 30, 2012 , a loss of $28. including ineffectiveness of $4 , was recognized in cost of products sold and a tax benefit of $7 was recognized in income tax expense. During the nine months ended September 30, 2012, a loss of $51, including ineffectiveness of $4 ,was recognized in cost of products sold and a tax benefit of $12 was recognized in income tax expense.

Fair Value of Outstanding Derivative Instruments in the Consolidated Balance Sheets
The following table sets forth the fair value hierarchy for the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2013 and December 31, 2012, respectively.

 
 
Balance Sheet Classification
 
Fair Value Hierarchy
 
September 30, 2013
 
December 31, 2012
Derivative Assets
 
 
 
 
 
 
 
 
Derivatives designated as hedges:
 
 
 
 
 
 
Foreign exchange
 
Other current assets
 
2
 
$
15

 
$
5

Commodities
 
Other current assets
 
1
 
1

 
5

Commodities
 
Other non-current assets
 
1
 

 
1

Derivatives not designated as hedges:
 
 
 
 
 

Foreign exchange
 
Other current assets
 
2
 
13

 
11

 
 
Total
 
 
 
$
29

 
$
22

 
 
 
 
 
 
 
 
 
Derivative Liabilities
 
 
 
 
 
 
 
 
Derivatives designated as hedges:
 
 
 
 
 
 
Foreign exchange
 
Accounts payable and accrued liabilities
 
2
 
$
17

 
$
6

Commodities
 
Accounts payable and accrued liabilities
 
1
 
26

 
17

Commodities
 
Other non-current liabilities
 
1
 
3

 
3

Derivatives not designated as hedges:
 
 
 
 
 

Foreign exchange
 
Accounts payable and accrued liabilities
 
2
 
7

 
4

 
 
Total
 
 
 
$
53

 
$
30

Schedule of Offsetting Derivative Assets and Liabilities
In the table below, the aggregate fair values of the the Company's derivative assets and liabilities are presented on both a gross and net basis, where appropriate.

 
Gross Amounts Recognized in the Balance Sheet
Gross Amounts Not Offset in the Balance Sheet
Net Amount
Balance at September 30, 2013
 
 
 
Derivative Assets
29

5

24

Derivative Liabilities
53

5

48

 
 
 
 
Balance at December 31, 2012
 
 
 
Derivative Assets
22

7

15

Derivative Liabilities
30

7

23


Notional Values of Outstanding Derivative Instruments in the Consolidated Balance Sheet
The aggregate U.S. dollar-equivalent notional values of outstanding derivative instruments in the Consolidated Balance Sheets at September 30, 2013 and December 31, 2012 were:
 
September 30, 2013
 
December 31, 2012
Derivatives in cash flow hedges:
 
 
 
Foreign exchange
$
632

 
$
471

Commodities
402

 
434

Derivatives in fair value hedges:

 

Foreign exchange
118

 
105

Derivatives not designated as hedges:
 
 
 
Foreign exchange
662

 
924